4.2 Review

Highlights of mechanisms and treatment of obesity-related hypertension

期刊

JOURNAL OF HUMAN HYPERTENSION
卷 36, 期 9, 页码 785-793

出版社

SPRINGERNATURE
DOI: 10.1038/s41371-021-00644-y

关键词

-

资金

  1. Roy J. and Lucille A. Carver College of Medicine Summer Fellowship in 2019
  2. Iowa Center for Research for Undergraduates Fellowship

向作者/读者索取更多资源

The prevalence of obesity has increased significantly from 1975 to 2015, with a strong link to hypertension. Excessive weight gain, especially when associated with visceral fat accumulation, accounts for a substantial portion of the risk of developing hypertension. Exercise and bariatric/metabolic surgery can lower blood pressure, while weight gain increases it, establishing a clear connection between these two factors. The mechanisms underlying obesity-related hypertension are complex and multifaceted.
The prevalence of obesity has increased two to three times from 1975 to 2015. Large-scale epidemiological and longitudinal prospective studies link obesity with hypertension. Research suggests that excessive weight gain, particularly when associated with visceral adiposity, may account for as much as 65% to 75% of the risk of incident hypertension. Also, exercise and bariatric/metabolic surgery significantly lowers blood pressure, whereas weight gain increases blood pressure, thus establishing a firm link between these two factors. The mechanisms underpinning obesity-related hypertension are complex and multifaceted, and include, but are not limited to, renin-angiotensin-aldosterone system/sympathetic nervous system overactivation, overstimulation of adipokines, insulin resistance, immune dysfunction, structural/functional renal, cardiac, and adipocyte changes. Though weight loss is the mainstay of treatment for obesity-related hypertension, it is often not a feasible long-term solution. Therefore, it is recommended that aggressive treatment with multiple antihypertensive medications combined with diet and exercise be used to lower blood pressure and prevent complications. The research regarding the mechanisms and treatment of obesity-related hypertension has moved at a blistering pace over the past ten years. Therefore, the purpose of this expert review is two-fold: to discuss the pathophysiological mechanisms underlying obesity-related hypertension, and to revisit pharmacotherapies that have been shown to be efficacious in patients with obesity-related hypertension.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据